GE HealthCare Profiled in Global Body Composition Analyzers Market Forecast

The global body composition analyzers market is projected to grow from $0.99 billion in 2026 to $1.39 billion by 2031, with GE HealthCare being one of the companies profiled in a recent market report. The growth is driven by rising demand in hospitals, clinics, and wellness centers, along with advancements in bioelectrical impedance analysis (BIA) technology. Bioimpedance analyzers are anticipated to experience the highest growth rate due to enhanced accuracy and connectivity features.